Targeting EGFR allosteric site with marine-natural products of Clathria Sp.: A computational approach
{{output}}
The EGFR-C797S resistance mutation to third-generation drugs has been overcome by fourth-generation inhibitors, allosteric inhibitors, namely EAI045 and has reached phase 3 clinical trials, so the Allosteric Site is currently an attractive target for developme... ...
